Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review

Laura Orsolini, Fabiola Sarchione, Federica Vellante, Michele Fornaro, Ilaria Matarazzo, Giovanni Martinotti, Alessandro Valchera, Marco Di Nicola, Alessandro Carano, Massimo Di Giannantonio, Giampaolo Perna, Luigi Olivieri, Domenico De Berardis

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Background: Schizophrenia is a complex illness in which genetic, environmental, and epigenetic components have been implicated. However, recently, psychiatric disorders appear to be related to a chronic inflammatory state, at the level of specific cerebral areas which have been found as well impaired and responsible for schizophrenia symptomatology. Hence, a role of inflammatory mediators and cytokines has been as well defined. Accordingly, the role of an acute inflammatory phase protein, the C-reactive protein (CRP) has been recently investigated. Objective: The objective of the present study is to evaluate how PCR may represent a biomarker in schizophrenia, i.e. correlated with illness phases and/or clinical manifestation and/or psychopathological severity. Methods: A systematic review was here carried out by searching the following keywords ((C-reactive protein AND ((schizophrenia) OR (psychotic disorder))) for the topics ‘PCR’ and ‘Schizophrenia’, by using MESH terms. Results: An immune dysfunction and inflammation have been described amongst schizophrenic patients. Findings reported elevated CRP levels in schizophrenia, mainly correlated with the severity of illness and during the recrudescent phase. CRP levels are higher when catatonic features, negative symptomatology and aggressiveness are associated. CRP levels appeared not to be related to suicidal behaviour and ideation. Conclusion: CRP and its blood levels have been reported higher amongst schizophrenic patients, by suggesting a role of inflammation in the pathogenesis of schizophrenia. Further studies are needed to better understand if CRP may be considered a biomarker in schizophrenia.

Original languageEnglish
Pages (from-to)583-606
Number of pages24
JournalCurrent Neuropharmacology
Volume16
Issue number5
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

C-Reactive Protein
Schizophrenia
Biomarkers
Inflammation
Polymerase Chain Reaction
Suicidal Ideation
Acute-Phase Proteins
Protein C
Epigenomics
Psychotic Disorders
Psychiatry
Cytokines

Keywords

  • C-reactive protein
  • Chronic illness
  • Inflammation
  • Psychosis
  • Schizophrenia
  • Systematic review

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Orsolini, L., Sarchione, F., Vellante, F., Fornaro, M., Matarazzo, I., Martinotti, G., ... De Berardis, D. (2018). Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. Current Neuropharmacology, 16(5), 583-606. https://doi.org/10.2174/1570159X16666180119144538

Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. / Orsolini, Laura; Sarchione, Fabiola; Vellante, Federica; Fornaro, Michele; Matarazzo, Ilaria; Martinotti, Giovanni; Valchera, Alessandro; Di Nicola, Marco; Carano, Alessandro; Di Giannantonio, Massimo; Perna, Giampaolo; Olivieri, Luigi; De Berardis, Domenico.

In: Current Neuropharmacology, Vol. 16, No. 5, 01.01.2018, p. 583-606.

Research output: Contribution to journalReview article

Orsolini, L, Sarchione, F, Vellante, F, Fornaro, M, Matarazzo, I, Martinotti, G, Valchera, A, Di Nicola, M, Carano, A, Di Giannantonio, M, Perna, G, Olivieri, L & De Berardis, D 2018, 'Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review', Current Neuropharmacology, vol. 16, no. 5, pp. 583-606. https://doi.org/10.2174/1570159X16666180119144538
Orsolini, Laura ; Sarchione, Fabiola ; Vellante, Federica ; Fornaro, Michele ; Matarazzo, Ilaria ; Martinotti, Giovanni ; Valchera, Alessandro ; Di Nicola, Marco ; Carano, Alessandro ; Di Giannantonio, Massimo ; Perna, Giampaolo ; Olivieri, Luigi ; De Berardis, Domenico. / Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. In: Current Neuropharmacology. 2018 ; Vol. 16, No. 5. pp. 583-606.
@article{757fc11587ee4f9aa5aa850c5faae854,
title = "Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review",
abstract = "Background: Schizophrenia is a complex illness in which genetic, environmental, and epigenetic components have been implicated. However, recently, psychiatric disorders appear to be related to a chronic inflammatory state, at the level of specific cerebral areas which have been found as well impaired and responsible for schizophrenia symptomatology. Hence, a role of inflammatory mediators and cytokines has been as well defined. Accordingly, the role of an acute inflammatory phase protein, the C-reactive protein (CRP) has been recently investigated. Objective: The objective of the present study is to evaluate how PCR may represent a biomarker in schizophrenia, i.e. correlated with illness phases and/or clinical manifestation and/or psychopathological severity. Methods: A systematic review was here carried out by searching the following keywords ((C-reactive protein AND ((schizophrenia) OR (psychotic disorder))) for the topics ‘PCR’ and ‘Schizophrenia’, by using MESH terms. Results: An immune dysfunction and inflammation have been described amongst schizophrenic patients. Findings reported elevated CRP levels in schizophrenia, mainly correlated with the severity of illness and during the recrudescent phase. CRP levels are higher when catatonic features, negative symptomatology and aggressiveness are associated. CRP levels appeared not to be related to suicidal behaviour and ideation. Conclusion: CRP and its blood levels have been reported higher amongst schizophrenic patients, by suggesting a role of inflammation in the pathogenesis of schizophrenia. Further studies are needed to better understand if CRP may be considered a biomarker in schizophrenia.",
keywords = "C-reactive protein, Chronic illness, Inflammation, Psychosis, Schizophrenia, Systematic review",
author = "Laura Orsolini and Fabiola Sarchione and Federica Vellante and Michele Fornaro and Ilaria Matarazzo and Giovanni Martinotti and Alessandro Valchera and {Di Nicola}, Marco and Alessandro Carano and {Di Giannantonio}, Massimo and Giampaolo Perna and Luigi Olivieri and {De Berardis}, Domenico",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1570159X16666180119144538",
language = "English",
volume = "16",
pages = "583--606",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review

AU - Orsolini, Laura

AU - Sarchione, Fabiola

AU - Vellante, Federica

AU - Fornaro, Michele

AU - Matarazzo, Ilaria

AU - Martinotti, Giovanni

AU - Valchera, Alessandro

AU - Di Nicola, Marco

AU - Carano, Alessandro

AU - Di Giannantonio, Massimo

AU - Perna, Giampaolo

AU - Olivieri, Luigi

AU - De Berardis, Domenico

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Schizophrenia is a complex illness in which genetic, environmental, and epigenetic components have been implicated. However, recently, psychiatric disorders appear to be related to a chronic inflammatory state, at the level of specific cerebral areas which have been found as well impaired and responsible for schizophrenia symptomatology. Hence, a role of inflammatory mediators and cytokines has been as well defined. Accordingly, the role of an acute inflammatory phase protein, the C-reactive protein (CRP) has been recently investigated. Objective: The objective of the present study is to evaluate how PCR may represent a biomarker in schizophrenia, i.e. correlated with illness phases and/or clinical manifestation and/or psychopathological severity. Methods: A systematic review was here carried out by searching the following keywords ((C-reactive protein AND ((schizophrenia) OR (psychotic disorder))) for the topics ‘PCR’ and ‘Schizophrenia’, by using MESH terms. Results: An immune dysfunction and inflammation have been described amongst schizophrenic patients. Findings reported elevated CRP levels in schizophrenia, mainly correlated with the severity of illness and during the recrudescent phase. CRP levels are higher when catatonic features, negative symptomatology and aggressiveness are associated. CRP levels appeared not to be related to suicidal behaviour and ideation. Conclusion: CRP and its blood levels have been reported higher amongst schizophrenic patients, by suggesting a role of inflammation in the pathogenesis of schizophrenia. Further studies are needed to better understand if CRP may be considered a biomarker in schizophrenia.

AB - Background: Schizophrenia is a complex illness in which genetic, environmental, and epigenetic components have been implicated. However, recently, psychiatric disorders appear to be related to a chronic inflammatory state, at the level of specific cerebral areas which have been found as well impaired and responsible for schizophrenia symptomatology. Hence, a role of inflammatory mediators and cytokines has been as well defined. Accordingly, the role of an acute inflammatory phase protein, the C-reactive protein (CRP) has been recently investigated. Objective: The objective of the present study is to evaluate how PCR may represent a biomarker in schizophrenia, i.e. correlated with illness phases and/or clinical manifestation and/or psychopathological severity. Methods: A systematic review was here carried out by searching the following keywords ((C-reactive protein AND ((schizophrenia) OR (psychotic disorder))) for the topics ‘PCR’ and ‘Schizophrenia’, by using MESH terms. Results: An immune dysfunction and inflammation have been described amongst schizophrenic patients. Findings reported elevated CRP levels in schizophrenia, mainly correlated with the severity of illness and during the recrudescent phase. CRP levels are higher when catatonic features, negative symptomatology and aggressiveness are associated. CRP levels appeared not to be related to suicidal behaviour and ideation. Conclusion: CRP and its blood levels have been reported higher amongst schizophrenic patients, by suggesting a role of inflammation in the pathogenesis of schizophrenia. Further studies are needed to better understand if CRP may be considered a biomarker in schizophrenia.

KW - C-reactive protein

KW - Chronic illness

KW - Inflammation

KW - Psychosis

KW - Schizophrenia

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=85048855806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048855806&partnerID=8YFLogxK

U2 - 10.2174/1570159X16666180119144538

DO - 10.2174/1570159X16666180119144538

M3 - Review article

C2 - 29357805

AN - SCOPUS:85048855806

VL - 16

SP - 583

EP - 606

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 5

ER -